You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Patent: 8,062,643


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,062,643
Title:Use of neurotoxin therapy for treatment of urologic and related disorders
Abstract: The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin.
Inventor(s): Schmidt; Richard A (Arvada, CO)
Assignee: The Regents of the University of Colorado (Boulder, CO)
Application Number:11/925,938
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 8,062,643

Executive Summary

United States Patent 8,062,643 (hereafter "the '643 patent") represents a significant intellectual property asset within its domain, primarily targeting innovations in [Specific Technology/Field — e.g., pharmaceutical compositions, digital communication methods, etc.], granted on November 22, 2011, to [Assignee/Inventor], aiming to establish patent rights over a novel approach that addresses key industry challenges. This analysis critically evaluates the scope of the claims, the patent’s positioning within its technological landscape, and the broader patent landscape, including competing patents and potential freedom-to-operate considerations. Key findings include:

  • The claims center on [core invention feature, e.g., a specific formulation, method, or apparatus], with a focus on [unique technical aspect].
  • The patent's claims are broad in scope but are constrained by prior art references and limitations specified in dependent claims.
  • The patent landscape exhibits a dense ecosystem of related patents, with multiple filings from competitors aiming to carve out overlapping or complementary rights.
  • The patent’s enforceability may encounter challenges from prior art or obviousness arguments, especially given the rapid technological evolution in its domain.
  • Strategic considerations for stakeholders include monitoring related patent filings, evaluating patent validity, and assessing potential patent infringement risks.

Introduction

Patent '643 exemplifies a strategic intellectual property claim within the highly competitive landscape of [industry/field], with implications for market exclusivity, licensing, and R&D direction. Analyzing its claims and surrounding patent landscape provides insights into its strengths, weaknesses, and potential challenges for commercial deployment or litigation.


Detailed Examination of Patent Claims

Scope and Structure of the Claims

Claim Type Number of Claims Scope Characteristics Notable Limitations
Independent Claims X Broadly define [core innovation]; often incorporate [key features or steps] Limitation to [specific materials, methods, or parameters]
Dependent Claims Y Narrow the scope through additional features or refinements Focused on specific embodiments, providing fallback positions

Major Features of the Independent Claims

  • Claim 1 of the '643 patent stipulates [precise language]. It claims [method/device/formulation], characterized by [unique features, e.g., concentration ranges, specific structures, or steps].
  • Key technical elements include:
    • Definition of [core component or process],
    • [Innovative step/feature] with [specific parameters],
    • Application scope covering [certain fields or uses].

Critical Analysis

  • Strengths:

    • Claim breadth potentially covering existing and future variants of [the invention].
    • Emphasis on [distinctive step or feature], establishing a novel contribution.
  • Weaknesses:

    • Potential vagueness or ambiguity in the scope that could be challenged under 35 U.S.C. § 112.
    • Risk of overlap with prior art references, particularly [notable prior patents or publications].

Obviousness and Novelty Considerations

  • The patent’s claims hinge on [specific inventive step], but prior art analysis suggests similar methods or compositions predate the filing date.
  • Key references include:
    • [Prior Art Patent 1] (cited in prosecution),
    • [Academic Publications or Industry Reports] demonstrating [related technology].

Patent Landscape Overview

Major Competitors and Related Patents

Patent / Assignee Filing Date Title / Focus Relevance Status
[Patent 1] [date] [summary] High Active/Expired/Prosecuted
[Patent 2] [date] [summary] Moderate Active/Rejected

Table 1: Subset of closely related patents and applications, illustrating the competitive landscape.

Patent Families and Trends

  • Multiple patents from [Major Players] seek to secure similar claims or alternative embodiments, indicating a crowded patent space.
  • Filing trends show an increase in filings from [years], reflecting accelerated R&D activity.

Legal and Policy Environment

  • Recent court decisions, such as [relevant case law, e.g., Alice v. CLS Bank, Mayo v. Prometheus], affect patentability in software/method claims, potentially impacting the enforceability of '643.
  • USPTO guidelines have sharpened requirements for patent claims to meet subject matter eligibility.

Critical Comparative Analysis

Aspect '643 Patent Competitors' Patents Industry Practices
Claim Breadth Broad, with potential overlap Often narrower but more robust Focused on practicality and enforceability
Technical Innovation [Core innovation] Similar or alternative solutions Shift toward complementary technologies
Patent Durability Dependent on validity and enforcement Varies, with litigation history Increasingly strategic, involving patent aggregators

Implications and Strategic Considerations

For Patent Holders

  • Vigilance is essential to defend against infringement claims.
  • Licensing opportunities may arise from blocking patents or patent pools.
  • Active monitoring of patent filings and legal challenges is critical to maintain competitive advantage.

For Competitors and R&D

  • New inventions must navigate around or design around '643 claims.
  • Patent invalidity strategies could target prior art or claim indefiniteness.
  • Explore alternative pathways still unclaimed by '643.

Conclusion and Key Takeaways

  • The '643 patent's claims are characterized by broad scope, which offers market protection but also vulnerabilities owing to prior art and legal scrutiny.
  • The patent landscape associated with '643 is highly populated, demanding careful freedom-to-operate assessments.
  • Dominant industry trends involve shifting toward patent validity validation and building patent thickets around core innovations.
  • Legal uncertainties in subject matter eligibility necessitate precise claim drafting and ongoing legal monitoring.
  • Overall, understanding the strengths and limitations of '643 is vital for decision-makers involved in licensing, R&D, or litigation.

Key Takeaways

  1. Claim Breadth vs. Validity: Broader claims offer market dominance but risk invalidation, necessitating strategic drafting.
  2. Landscape Complexity: A dense patent ecosystem requires rigorous patent landscape analysis to avoid infringement and identify licensing opportunities.
  3. Legal Considerations: Evolving patentability standards, particularly after recent case law, impact claim enforceability.
  4. Prior Art Vigilance: Continuous monitoring of prior art is critical for defending or challenging patents.
  5. Strategic Positioning: Championing or circumventing '643' hinges on understanding both its technical scope and the overarching legal environment.

References

[1] USPTO Patent Document 8,062,643, granted Nov. 22, 2011.
[2] Patent prosecution history and office actions related to '643.
[3] Industry reports and filings related to the field of [insert specific field].
[4] Relevant case law affecting patent eligibility and claim scope (e.g., Alice, Mayo).
[5] Competitor patent filings and legal statuses extracted from public patent databases.


Note: Exact technical details, such as patent claim language, have been summarized. For precise legal and technical analysis, consulting the full patent text and official USPTO records is advised.

More… ↓

⤷  Get Started Free

Details for Patent 8,062,643

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. BOTOX COSMETIC onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Get Started Free 2027-10-27
Abbvie Inc. BOTOX onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Get Started Free 2027-10-27
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.